4 / 13
Page 18
Notes:
Volume 3
Journal of Pharmacology and Medicinal Chemistry
Nanomedicine 2019
Biotechnology 2019
May 20-21, 2019
May 20-21, 2019 London, UK
4
th
World Biotechnology CONGRESS
Nanomedicine and Nanotechnology
4
th
International Conference on
&
The role of thioredoxin reductase in gold nanoparticle radiosensitization effects
Sebastien Penninckx
University of Namur, Belgium
Aim:
To identify new mechanisms responsible for the radiosensitization effect of gold nanoparticles (GNPs).
Materials & Methods:
Five different cell lines were incubated with homemade 10 nm GNPs 24h before to be exposed to 25
keV/µm protons or 225 kV X-rays.
Findings:
GNP incubation with lung carcinoma cells led to a time-dependent mitochondria membrane depolarization, oxidative
stress and to X-ray and proton radiosensitization. Moreover, a marked inhibition of thioredoxin reductase (TrxR) was observed.
Irradiation of cells invalidated for TrxR evidenced a radiosensitization effect, suggesting that this enzyme is a potential GNP
target. Furthermore, we reported that this TrxR activity reduction is cell type-dependent and lead to differences in cell response
to X-ray irradiation. Correlation analyses demonstrated that GNP uptake and TrxR activity inhibition are associated to GNP
radiosensitization effect. Finally, Kaplan-Meier analyses suggested that high TrxR expression is correlated to low patient survival
in four different types of cancer.
Conclusions:
We suggest that GNPs play a radiosensitizer role by weakening detoxification systems. All together, these
results enable a better understanding of GNP radiosensitization mechanisms which remain a mandatory step towards
further use in clinic. Moreover, they highlight the potential application of this new treatment in a personalized medicine
context opening up novel promising strategies for the development of nanotechnologies associated to radiotherapy.
Biography
Sebastien Penninckx got a master’s degree in chemistry at Free University of Brussels (Belgium). He then defended his PhD thesis in
physics and biology at University of Namur (Belgium) in February 2019. In recent years, he has built bridges between nanotechnology
and biophysics in close collaboration with transdisciplinary teams in the research institute NARILIS in the UNamur. During his PhD
thesis, he has spent 3 months at UC Berkeley (California, USA) and NASAAmes Research Center (USA) where he studied cancer risk
prediction for astronauts exposed to ionizing radiations during spacecraft missions.
sebastien.penninckx@unamur.beJ Pharmacol Med Cheml, Volume 3